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A B S T R A C T
Objective: To understand the contribution of the Medicines Use Review consultation to counseling
practice in community pharmacies.
Methods: Qualitative study involving ten weeks of observations in two community pharmacies and
interviews with patients and pharmacy staff.
Results: ‘Traditional’ counseling on prescription medicines involved the unilateral transfer of
information from pharmacist to patient. Over-the-counter discussions were initiated by patients and
offered more scope for patient participation. The recently introduced MUR service offers new
opportunities for pharmacists’ role development in counseling patients about their medicines use.
However, the study ﬁndings revealed that MUR consultations were brief encounters dominated by
closed questions, enabling quick and easy completion of the MUR form. Interactions resembled
counseling when handing out prescription medicines. Patients rarely asked questions and indeterminate
issues were often circumvented by the pharmacist when they did. MURs did little to increase patients’
knowledge and rarely affected medicine use, although some felt reassured about their medicines.
Pragmatic constraints of workload and pharmacy organisation undermined pharmacists’ capacity to
implement the MUR service effectively.
Conclusion: Pharmacists failed to fully realise the opportunity offered by MURs being constrained by
situational pressures.
Practice implications: Pharmacist consultation skills need to be reviewed if MURs are to realise their
intended aims.
 2011 Elsevier Ireland Ltd. 
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Reforms to the United Kingdom (UK) community pharmacy
contract in England and Wales in 2005 sought to address
pharmacy’s heavy reliance on dispensing prescriptions to generate
income by moving to reward patient-centred services [1,2]. The
‘Medicines Use Review and Prescription Intervention’ (MUR)
service is one of a number of policy initiatives which seek to help
people better manage their medicines as well as reduce the cost of
wasted and inappropriate use of medicines [1,3,4]. MURs involve
pharmacists undertaking a private consultation with the patient
and aim to improve ‘knowledge, concordance and use of medicines’
[3]. The MUR involves completion of a national standard form.§ I conﬁrm all patient/personal identiﬁers have been removed or disguised so the
patient/person(s) described are not identiﬁable and cannot be identiﬁed through
the details of the story.
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Kingdom. Tel.: +44 (0)115 846 6254; fax: +44 (0)115 846 6249.
E-mail address: paxal@nottingham.ac.uk (A. Latif).
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Open access under CC BY license.Information that the pharmacist is expected to elicit from the
patient in order to complete the form includes whether they use
the medicine as prescribed, whether they know the medicine’s
purpose, if the formulation is appropriate and reported side effects.
The format of the form is tick-box allowing a yes/no response to
questions [3]. Patients are eligible for the service if they are taking
two or more medicines and have been receiving pharmaceutical
services from the pharmacy for at least three months. Pharmacies
are entitled to claim £28 reimbursement from the NHS for each
MUR performed with an annual maximum of 400. In England, 1.7
million MURs were conducted in the 2009–2010 ﬁnancial year
costing a total of £47.7m [5]. Pharmacists are required to include,
in their discussion, both prescribed and over-the-counter (OTC)
use of medicines within the MUR. The MUR initiative is in tune
with other UK health policy commitments such as patient choice
[6,7], re-shaping care around the patient [8] and greater
involvement of patients in their medicines management [9].
Similar medication review schemes are provided in Australia [10],
United States [11] and New Zealand [12]. Formalising the
pharmacist’s counseling role by providing payment, represents a
means to enhance professional status. Greater emphasis on patient
Box 1. Patient interview topic guide
Demographic details
About the MUR:
1. Opening question: could you tell me from beginning to the
end your experience of the MUR in as much detail as
possible?
2. Respondent’s awareness of MUR service & views of being
approached.
3. Respondent’s expectations & views of purpose of the MUR.
4. Exploration of what happened during the MUR (using ob-
servation notes).
5. Views on necessity/usefulness/would respondent like to
have discussed anything?
6. Affect knowledge or use of medicines?
7. Likes and dislikes about review?
8. Who in your opinion would most benefit from MUR?
9. Improving the service/another MUR in future?
Pharmacy use & perceptions around role of the pharmacist.
Respondent’s medicines & medical care.
1. Beliefs, necessity and concerns over medicines.
2. Perceived authority over medicines.
3. GP & other health professional role in respondent’s care.
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and those wishing to reprofessionalise pharmacists’ activities
[13–15].
Most patient–pharmacist interactions still occur on the ‘shop-
ﬂoor’ when the pharmacist supplies dispensed medicines to
patients. This encounter, described in the UK as ‘counseling’,
typically seeks to ensure that the directions on the labels of
dispensed products are understood [16]. Variations have been
reported in how pharmacists counsel on prescribed medicines;
for example, information on directions, medicine name, and
indications for use were given more frequently than information
on side effects, cautions and interactions [17,18]. However, the
community pharmacist’s consultative role remains undeveloped
and the concept of patient counseling ill deﬁned [19]. Shah and
Chewning [20] found that the deﬁnition of patient counseling
varied across studies with half conceptualising patient–pharma-
cist communication as information provision. The predominantly
information-based focus of patient–pharmacist interaction
means that counseling in the pharmacy context carries a
somewhat different meaning to that in other settings, such as
psychotherapy, where there is a process of subjective scrutiny
and greater engagement with, and contribution from, the client
[19,21].
Another patient–pharmacist interaction relates to OTC sales of
medicines. These are initiated by the patient and involve the offer
of a professional opinion about a course of action, whist allowing
the ﬁnal decision to lie with the patient [22]. This level of
indeterminacy requires negotiation and contrasts with counseling
offered on dispensed medicines where patients’ information needs
may be assumed to have been addressed by the General
Practitioner (GP) [21]. Although OTC interactions potentially offer
more scope for the pharmacist to explore patient perspectives and
concerns, they are usually problem-speciﬁc and have attracted
criticism as lost opportunities to discuss wider health issues
[21,23].
MURs present an opportunity for pharmacists to extend their
currently limited counseling role in wider discussions of patient
beliefs and concerns about their medicines. This paper aims to
contextualise and better understand MUR consultations as they
occur in the ‘real world’ setting of pharmacy practice and explores
what they may additionally offer over ‘traditional’ patient–
pharmacist interactions for prescription and OTC medicines.
2. Methods
Following approval from a local NHS Research Ethics Commit-
tee, two pharmacies, a multiple and an independent were recruited
purposefully via personal contacts. Consent was obtained from the
pharmacists and support-staff for ﬁve weeks of observations in
each pharmacy. One-week placements over a 12-month period
between November 2008 and October 2009 allowed the data
collection and analysis phases to proceed simultaneously. Phar-
macies were requested to display posters within the pharmacy to
promote patient awareness of the study.
Observation notes were made (by AL) of all pharmacy activities,
the working environment, staff–patient conversations and all
activities relating to MURs. Ethnographically orientated unstruc-
tured observation methods were used which involved detailed
observation of behaviour and talk to better understand the social
setting in which people function in their natural environment. AL
recorded all aspects of the phenomenon and the context in which
they occurred that seemed relevant to the situation being studied.
This produced rich qualitative data in order to uncover behaviours
or patterns of which the participants themselves may not have
been aware [24]. The triangulation of direct observation (research-
er’s accounts) with accounts provided by respondents in inter-views provided a powerful means of understanding the complexity
of respondents’ views, how these may shift contextually, the
situational pressures which underlie them, and the resulting
difference in what people ‘say’ and what they ‘do’ [25].
All pharmacists and support-staff were requested to identify
and invite patients for MURs as per normal practice and to
introduce the research to all those who accepted the offer of an
MUR. All such patients agreed to be included in the research and for
their MUR to be observed, at which point AL was introduced and
explained what was involved. Thus, AL was able to observe nearly
all MURs taking place during the period of ﬁeldwork while he was
undertaking observation in the pharmacies. All extracts from the
observation notes that are presented in this paper are taken from
detailed notes written up after each observation, rather than
verbatim quotes. Pseudonyms have been used in quoted extracts to
maintain respondents’ anonymity.
After the MUR patients were invited to take part in an interview
about their experience. A topic guide was developed and tailored to
the speciﬁc details and context of the MUR which preceded it (Box
1). The topic guide was used to stimulate an open discussion of
topics and issues that were most salient for respondents rather
than to impose the researcher’s framework of understanding [25].
After the pharmacy observations, pharmacists and support-staff
interviews were held to discuss their perceptions of MURs. Topic
guides were developed to explore pharmacist (Box 2) and support-
staff (Box 3) perceptions of the MUR service. As with the patient
interviews, staff interviews were individually tailored to clarify,
conﬁrm and extend the observational data.
2.1. Analysis
Data analysis started during the early stages of data collection.
The focus of the observations and the interview topic guide were
revised during the data collection period. This inductive approach
is considered to be good qualitative practice [25,26]. All
observation ﬁeld note documents were typed up and all the
interviews transcribed verbatim. The data were then imported
into N-Vivo8.
A thematic approach to analysing the qualitative data was used
and involved initially reading and re-reading each section of the
text and collating them under different headings or ‘codes’. The
aim of coding is to ensure all the data that relates under the same
Box 2. Pharmacist interview topic guide
Demographic data & accreditation process.
Pharmacist’s experience of MURs:
Patient selection.
Views & use of MUR forms.
Necessity of MURs.
Most common concerns patients have about their medicines?
Organisational pressure & targets.
Professional boundaries.
Objectives of MUR:
What do you hope to achieve? Good outcome/bad outcome.
View on improving knowledge and use of patients’ medicines.
Resolving patient’s ineffective use of medicines & examples.
How often do you make suggestions/are these accepted?
Views on value for money for NHS.
Support:
Do you welcome MURs/has this added anything to your role?
What support have you had to help you develop the service?
(employers, local surgery, Primary Care Trust)
How can MURs be improved?
Box 3. Pharmacy support-staff interview topic guide
Demographic data.
Training received.
Patient selection.
Identifying patients.
Explore patient responses.
Organisational issues:
View on pharmacist performing MURs.
Managing work without pharmacist.
Examples where the pharmacist was needed but was unavail-
able & patient response.
Organisational pressures & MUR targets.
Box 4. Illustrative section from the coding framework. A se-
lection of sub-codes is provided with an example of associated
text for the main code ‘workload pressures and targets’
Workload pressures and targets:
Workload pressure. . . the dispensing bench had several piles of
prescriptions. . .to be checked by the pharmacists. Jane [phar-
macist] had decided that the workload was too much. . .she told
Kate [pharmacist] that ‘we need to catch up so just book MUR
appointments’. . .there was no negotiation. . .Subsequently no
MURs were performed that afternoon. Extract from observa-
tion notes. Multiple pharmacy.
Patient views on pharmacist performing MURs:
Beth: I know they’re very busy people these pharmacists aren’t
they. . . they’re always rushed off their feet. . .I don’t think they
should be pulled from there to do that sort of work, in that
room, reviews and then have to go back again. . .sometimes
that’s how mistakes are made, they’re rushed. . . Patient in-
terview, Multiple
MUR targets:
Rebecca: Well, she kind of tries to set a target, but does
understand when it’s not met. . .she does say ‘‘try and do
one MUR a day’’ but then, realistically, when she looks at
the figures she’s not sort of on your case. . . Employee phar-
macist interview, Independent
Support-staff views on targets:
Dawn:. . .Nothing should be causing pressure like that when
you’re dealing with medication. . .You shouldn’t have tar-
gets. . .It should be as and when a customer, you feel, needs
a medication review. It shouldn’t be about, you’ve got to do ten
today. Because if you do ten and you don’t give them the
quality of service, what’s the point in it...? Support-staff
(dispenser) interview, Multiple.
Box 5. Coding framework for OTC, dispensing and MUR
counseling interactions
OTC:
Accessible advisor
Patient expectations/establishing need
Resolver of problems
Patient ambiguity of role
Commercial environment & influence on counseling
Range of OTC counseling
Emergency hormonal contraception consultations &
confidentiality
Nicotine replacement therapy consultations
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interview transcripts and observation ﬁeld notes were constructed
based upon what was observed and reported in interviews. Box 4
provides an illustration of a section of the coding framework that
was developed for the code ‘workload pressures and targets’.
Coded extracts were then systematically read through and the
contents condensed so that all the different issues that were raised
were recorded. Consideration was then given to how these issues
might be grouped together in broader themes which were then
synthesised and narrated. The principle of constant comparison
were used to test and reﬁne these themes. A detailed explanation
of the data analysis process used is described by Ziebland and
McPherson [26].
3. Results
3.1. Study sites
The multiple pharmacy was located in a relatively afﬂuent
town, on a busy high street. The healthcare counter was located at
the rear of the shop alongside the dispensary. The area did not
allow private discussions so people could be overheard when
speaking to pharmacy staff. The consultation room, installed to
provide the MUR service, was located nearby and seldom used forother purposes. The room was well lit and contained two chairs
and a small table.
The independent pharmacy was in a similarly afﬂuent but
residential suburb. The dispensary was behind the healthcare
counter towards the rear and raised above the rest of the
shop. Again there was no obvious place for private discussion.
The consultation room was next to the dispensary and had
been adapted for MURs from an existing ofﬁce. The room had a
window with net curtains allowing privacy and was rarely
used for discussions with patients other than MUR consultations.
3.1.1. Pharmacist counseling during supplies of prescription
medicines
Field notes included observations and reﬂections from 114
patient-staff dispensing interactions (see Box 5 for coding frame-
work). Observations revealed that most patients came to the
dispensary to ﬁll their prescriptions. Patients’ initial interaction was
usually with pharmacy support-staff and limited to enquiries about
when the patients’ medicines would be ready to collect. Phrases
typically used by the pharmacy staff to indicate their agenda to ﬁll
Other OTC pharmacy activities
Indeterminacy in OTC work
Lack of information during interactions
Organisational culture
Power struggle patient/pharmacist/GP
Privacy
Rapport with patients
Support-staff referrals
Work flow management
Dispensing:
Double checking with patients
Role as checker
GP issues & influence
Law bound
Subordinate to GP
Environment – not facilitative for counseling
Lack of information
Range of dispensing counseling
Medidose
Methadone
Prescription
Paternalism
Points out changes
Pharmacist holds specialist knowledge
Pharmacist activities viewed by patients
Pharmacist as controller of medicines
Pharmacist definitive source of information
Pharmacist sociable
Pharmacist natural attitude
Resolver of practical medication issues
Refers to GP when required
Resolver of dispensing errors
Trust
Will NOT explore issues further
MUR:
Space issues in consultation room
Initiation of MUR
Lack of patient focus
Appears rushed
Confusing or inappropriate questions (pharmacist)
What is happening in MUR
Checking medication
Expert patient
Missed interactions
Problems establishing use
Educating patients
Information giving
Informing about changes
Resolving side effects
Patient confusion about MUR
Patient education about MURs
MURs as big brother
Explaining medication use
Gray or indeterminate area
Identifying potential future problems
Interpersonal relationship
Lacks patient focus
Other issues not medicine linked
Patient asks about side effects
Patient happy with response
Problem with medications
Prescriptive nature of MUR
Problems of establishing patient use of medication
Pharmacist does not know answer
Patient aversion to medicines
Superficial questions/lack probing
Time pressures
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10 minutes. Do you have any shopping to do?’ Pharmacists were
heavily involved in the dispensing process and their interactionswith patients were brief and primarily to hand out medicines. The
information provided was often generic in nature:
Rebecca [pharmacist]: This is a new item isn’t it?
Patient: Yes. [Mentions it is for his shoulder]
Rebecca: Yes, ok then. [Patient describes his shoulder pain. Rebecca,
turning sideways provides a cue that she wants to return to the
dispensary].
Rebecca: It can cause drowsiness.
Patient: That’s what the doctor said. Is there enough to last me for a
fortnight?
Rebecca: If you take less than 8 a day, then yes. Bye.
Observation Wk2 Independent
The above extract is a representative illustration of the unilateral
approach that pharmacists took to counseling [19]. In this case,
information about drowsiness was transmitted without ﬁrst
establishing whether the patient understood or was knowledgeable
about this. During routine collection of prescriptions, information
was typically delivered in an instructional manner with little two-
way communication as illustrated by the following representative
extract:
Jane [pharmacist]: There’s a note on your prescription that your
metformin has been reduced from three times a day to twice a day,
is that right?
Patient: Yes.
Jane: Do you know about that?
Patient: Yes.
Jane: I wanted to make sure.
Observation Wk3 Multiple
Patients appeared comfortable with, or at least to accept this
arrangement, for the provision of information. Questions asked by
the pharmacist such as ‘have you had this before?’, ‘has the doctor gone
through this with you?’ or ‘do you know your dose of [medicine] has
been increased?’ received minimal responses from patients. Others
have argued that the scope for providing new advice to patients is
limited [21]. Occasionally, patients’ asked questions, but these were
mostly to clarify the practicalities of taking the medicine, such as the
dose. There was an assumption that patients knew about their
repeat medicines. However, evidence suggests that this may not be
the case and additional support may be required [27,28] even
though patients may believe that routine information on repeat
medication is unnecessary and pharmacists are accessible for
further information if required [29,30]. Pharmacists, working within
real life constraints of a busy dispensary, were not observed actively
identifying patients who may have needed additional support but
rather conﬁned their input to conﬁrming the doctors’ instructions.
3.1.2. Pharmacist–patient interactions over-the-counter
Field notes included observations and reﬂections on 100
customer-staff OTC interactions (see Box 5 for coding framework).
The wide range of medicines and retail products available meant
A. Latif et al. / Patient Education and Counseling 83 (2011) 336–344340that there was an apparent freedom for customers to ask about a
variety of health issues. OTC sales of medicines were routinely
undertaken by medicines counter assistants (MCA). Customer–
MCA interactions have been shown to be complex, characterised
by multiple discourses in which both parties commit, to legitimise
the MCA as a medical advisor [31]. Customer–pharmacist
discussion in OTC interactions tended to be conversational and
tailored to patients’ speciﬁc requests for advice and information:
Customer: Which is better? [Holds up two athletes foot products]
Jane [Pharmacist]: Is the inside moist or dry?
Customer: It’s dry.
Jane: It’s best to go for the cream. If it was moist you could have
used the powder to dry it up. . .
Customer: Do you want to look? [Shows foot]
Jane: It looks moist, so use the powder. . .and you can use it in the
socks as well. . .
[Patient purchases the medicine]
Observation Wk3 Multiple
As is illustrated in the above extract OTC discussions were more
open and conversational in nature than counseling on prescribed
medicines. In ﬁelding enquiries directly from customers, the
pharmacist often needed to establish something about the
customers’ circumstances and an understanding of the problem
before recommending a treatment. The interactional focus was
more ‘patient-centred’ or, as previous literature suggests, con-
sumer-led [21]:
[A woman enquires about a new anti-obesity drug]
Customer: It goes straight through does it? [Yes]. I don’t want to use
it then because I use cod liver oil in the morning . . .I don’t have to
take it in the morning do I?
Rebecca [Pharmacist]: No. You can take it at lunchtime and in the
evening.
[Discussion continues, after which patient purchases the medicine]
Observation Wk5 Independent
In this illustrative extract the pharmacist discussed with the
customer adjusting the dose of the medicine according to her
needs. However, the pharmacist neglected to enquire into the
customer’s lifestyle or other matters that may have been relevant
to her weight management. Nevertheless, many OTC interactions
served to address speciﬁc customer-initiated requests for advice
and resembled what Pilnick describes as a ‘stepwise’ counseling
approach, where knowledge and competence were explored in the
encounter [19]. In these circumstances, customers who
approached the pharmacy staff for advice appeared both familiar
with and accepted the role of the pharmacist as an accessible
adviser. However, the shop-ﬂoor environment was not conducive
to more detailed or personal discussions.
3.1.3. MUR interactions
3.1.3.1. Participant response rate. Fifty-four patients gave consent
for AL to observe their MUR consultation [32] and 34 patients
agreed to be interviewed about their experience of the MUR. Mostpatient interviews were conducted at the pharmacy (two at the
University), lasted around 45 minutes and all were audio-recorded.
3.1.4. The MUR consultation (see Box 5 for coding framework)
When inviting patients, pharmacists and staff often presented
the MUR as a quick activity to ‘‘check’’ their medicines. Once
patients had agreed and were seated, MUR consultations followed
a similar pattern, directed by the pharmacist’s use of the MUR
form. Some patients reported surprise at being approached ad hoc.
This was a deviation from the standard pharmacist interaction
described above, and to which they were accustomed and so they
felt unprepared for an extended consultation. However, most did
not mind this approach [33]. Pharmacists began with a brief
explanation of the purpose of the MUR. Patient–pharmacist roles
and expectations were therefore constructed from the onset
through the pharmacist’s announcement of the agenda:
Kate [Pharmacist]: This is to check your medicines that you’re on
and that they’re not interacting with anything over-the-counter. . .
MUR 30 – Multiple
A question–answer sequence then followed where the pharma-
cist would ask the patient questions about their prescribed and OTC
medicines. This enabled the MUR form to be completed quickly. All
pharmacists were observed simultaneously completing the MUR
form and talking to patients. Patients typically offered minimal
responses to the closed nature of the pharmacist’s questions:
Jane [Pharmacist]: The Feldene, how often do you use it? [Patient
replies that she uses it when she gets arthritis].
Jane: So you know what it’s for?
Patient: Yes.
Jane: You don’t get any irritation?
Patient: No.
Jane: The cetirizine, you know what that’s for?
Patient: A rash.
Jane: Are you alright swallowing that?
[MUR continues]
MUR 11 – Multiple
This extract illustrates the procedural way most MURs were
carried out by this pharmacist. All pharmacists dominated the
consultation with nearly half of all patients observed not to ask any
questions during the encounter (Table 1). Pharmacists did allow
patients to talk and responded adequately to queries such as whether
medicines could be taken together. However, they relied heavily on
reference to the prescriber’s instructions to circumvent or close
down discussion of more indeterminate medicine-related matters:
Jane [Pharmacist]: The ﬂeconide, you take two twice a day?
Patient: I take one twice a day.
Jane: The doctor’s got you down as two twice a day.
Patient: I take one in the morning and one at night.
Jane: You need to have a word with the doctor. . .
MUR 19 – Multiple
Table 1
Demographic data and characteristics of MUR consultations (n = 54).
Outcome measure Independent pharmacy Multiple pharmacy
Number of MURs observed 21 33
Patient gender
Men 7 8
Women 14 25
Mean age of patients (range) 65 (46–81) 72 (40–89)
Number of patients invited by the pharmacy staff ad hoc or via appointment
Ad hoc 17 31
Appointment 4 2
Mean number of medicines per patienta (range) 8 (2–17) 6 (2–11)
Mean number of questions asked by the pharmacist during the MURb 10 14
Number of patients who did not ask any questions during the MUR 12 (57%) 13 (39%)
Of the remaining patients, mean number of questions asked per patients (range) 2 (1–4) 3 (1–9c)
Number of patients who previously had an MUR (revealed in the patient interview) 5 in 17 interviews 7 in 17 interviews
a This was the number of prescribed and OTC medicines that were mentioned by the pharmacist or patient during the MUR and interviews.
b The number of direct questions asked by pharmacists is presented here. However, pharmacists also used statements to conﬁrm that patients were taking a particular
medicine or taking a particular dose. These have not been included in the count.
c There was one MUR where a patient and a carer were both present. Nine questions were asked; the carer asked ﬁve questions (one about his own health) and the patient
asked four questions.
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use of medicines, patients often spoke of their illness. In several
MURs pharmacists were seen to be cautious about prying into
patients’ medical affairs and in their interviews revealed an
aversion to discussing sensitive issues. As is exempliﬁed by the
following extract the format of the MUR did not facilitate a
discussion of the patient’s medical condition or related concerns:
Rose [Pharmacist]: The Gaviscon, do you take two spoons at night?
[Pharmacist enquires why]
Patient: [yes] . . .for silent reﬂux. It occurs when tiny particles of
acid make their way up the oesophagus, damaging the vocal
chords. . .They don’t know if it’s silent reﬂux or an ulcer
Rose: I’m going to put here ‘nerves not kicking in properly’. I don’t
need to give you any more information, but you probably know
that it forms a raft on the contents of your stomach and so it
prevents the reﬂux. . . [Conversation turns to the next medicine].
MUR 7 – Independent
The above extract shows a lack of pharmacist’s curiosity to
explore the uncertainty expressed by the patient about her
diagnosis resulting in a lost opportunity to discuss something the
patient might have found useful. Instead, the pharmacist provided
information about how the medicine worked. Likewise, pharma-
cists were observed frequently embedding unsolicited advice
about side effects on medicines in their discourse with patients. On
a few occasions, patients did indicate during the MUR that they
found the information provided useful:
Patient: I have some antihistamines. . . that’s ok isn’t it with the co-
proxamol?
Rebecca [Pharmacist]: If they’re the one-a-day ones then they’re
ﬁne with everything that you’re on. . .if you have dry eyes, and you
ﬁnd that you are using the drops more, than it might be the
antihistamines that are doing that.
Patient: That’s worth knowing. . .
MUR 13 – Independent
Patients accepted advice when the pharmacist was able to
frame the perceived beneﬁts for the patient or convince them of
avoiding future harm:[Conversation turns to the patients’ knee pain]
Patient: He [GP] did tell me to take glucosamine. . .
Jane [Pharmacist]: . . .With condroitin, now you need to talk with
the diabetic nurse about this as they have found that it can interfere
with your diabetes. . .
MUR 15 – Multiple
As a result of his MUR, the patient had stopped his glucosamine
tablets and was going to speak to the diabetic nurse and his GP.
Although the patient was content to do this, the pharmacist did not
feel the need to contact the nurse or GP directly. Likewise, when
patients revealed an unusual side effect or reported following
personal regimes of medicine taking, the pharmacist dealt with
these issues in a succinct and apparently superﬁcial manner:
Patient: . . .I ﬁnd sometimes at night if I take three paracetamol for
the pain it works.
Rebecca [Pharmacist]: You shouldn’t really do that.
Patient: I ﬁnd if I take three when the pain is bad it gets me to sleep.
Rebecca: Well, it’s best to take two.
Patient: I don’t do it often. . .
MUR 18 – Independent
As the extracts illustrate, the response of the pharmacist allowed
the MUR to continue. However, the patient revealed in her interview
a lack of acceptance of the pharmacist’s advice as she reported that
she would persist in her habit of taking three paracetamol. Rather
than working with the patient, pharmacists took an inﬂexible view
in circumstances where medication was being used in ways other
than had been prescribed. The questions asked during the MUR
consultation were therefore not focused on how to manage the
patient’s illness better with the aid of medicines, but whether the
medicines were being used in a way that was acceptable in terms of
the pharmacist’s opinion and advice. Pharmacists occasionally asked
at the end of the MUR whether the patient had any questions about
their medicines; few responded to take up the invitation.
3.1.5. Patient experiences
Patients’ reported being unfamiliar with the MUR, supporting
previous research indicating patients’ low expectation and
Box 6. Representative quotations from patient and staff inter-
views
Patient interviews
Theme: awareness and invitation:
Researcher: Do you remember how you were approached
initially?
Primrose: The lady came up to me and said would I mind going
through my medication with the pharmacist and just to kind of
make sure that we both knew why this medication was being
prescribed and it was just something that chemists are having
to do now.
Patient interview – Independent
Researcher: Were you expecting a review?
Nick: No [laugh] no, Jane [pharmacist] just collared me [laugh-
ter].
Patient interview – Multiple
Theme: knowledge and use of medicines:
Eve: The only thing I was more knowledgeable about was
when she told me it was all right to take them like that [to take
tablets together]. . .it put my mind at rest. . .
Patient interview – Independent.
Jill: [Sighs] Well I don’t think I’ve got no more knowledge, I
think it’s just that I’ve been on these for so long, and once
you’ve been on them for so long the doctor does makes sure
that you’re alright with them.
Patient interview – Multiple
Pharmacist interviews
Theme: workload issues:
Linda: . . .I’m quite keen on them [MURs] but it’s a time restraint
and don’t feel like I want to rush people through doing one, but
I don’t want to feel stressed that I’ve got staff out in the shop
getting stressed because the customers are getting stressed
because you’re not there and what have you...
Locum pharmacist, Independent
Researcher: . . .how conscious are you that you’re going to be
returning to a full checking bench?
Jane: Very. You can’t switch off from the fact that you know
that’s going on. And that’s in the back of your mind. . .when
you know that you’re exceptionally busy, it puts you under a
pressure and you really just want to get through that, those
questions as quickly as possible. Because, you know you’re
going to go back to bedlam. . .You can’t switch off from that,
because that’s part of your responsibility as well.
Employee pharmacist, Multiple
Theme: MUR target & pressure:
Rebecca: . . .And I think Rose [owner] definitely understands
though, which is why she has totally said that, I know it’s very
difficult to go from a busy setting, like you say, in the checking
mode, in that mode and then to go to this whole consultative
role. . .
Employee pharmacist, Independent
Researcher: . . .what support have you had with these Medi-
cines Use Reviews? Apart from the support to be accredited?
Kate: Yeah, no, they just pretty much throw you in at the deep
end, they just don’t want to know. They just want to know if
you’re meeting target. . .
Employee pharmacist, Multiple
Support-staff interviews
Theme: Absent pharmacist:
Lucy: I think it’s frustrating from the fact that you know people
are waiting for prescriptions and you’re having to say ‘the
pharmacist has got a patient in with her at the moment’. People
just want to go, don’t they? They want their prescription,
they’re not bothered about why she’s interviewing another
patient. . .
Dispenser, Independent
Leah: There’s also people that come in and ask specifically to
speak to the pharmacist . . . they don’t want us, they want the
pharmacist. . .
Counter assistant, Multiple
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interviewed reported previously having had an MUR; however,
few could remember any details of this or actions taken as a result.
The lack of purpose for the MUR, patients’ inability to set their own
agenda, as well as the structured way the consultation was framed,
left some patients with the impression they were helping with a
task the pharmacist was required to complete rather than taking
part in a consultation for their own beneﬁt:
Esther: I don’t mind, to me if I can help...I like to do it and it makes
me feel good that I’ve helped somebody. . .
Patient interview – Independent
Most patients reported their MUR had not improved their
knowledge and rarely affected their use of medicines (Box 6). Many
patients already felt knowledgeable about medicines that had been
prescribed for their long-term conditions. Nevertheless, a few
patients reported parts of their MUR to be useful:
Mia: . . .she said you need to go and see the asthma nurse. . .I
thought I was on the most I could go on and I’d have to tolerate it
but she said that they can help you more. . .
Patient interview – Multiple
Comfort: I think it gives you more conﬁdence, it does me, gives me
more conﬁdence to think I’m doing the right thing and taking the
right medicine
Patient interview – Multiple
Most patients appreciated and valued the time the pharmacist
spent with them and described the MUR as ‘‘satisfying’’ or
‘‘interesting’’. The pharmacist was viewed as a knowledgeable
expert and this served to reassure patients about their medicines
(Box 6).
3.1.6. Staff views
3.1.6.1. Participant response rate. All pharmacy staff within both
pharmacies were invited to be interviewed to discuss their
perceptions of MURs. Five pharmacists who had been observed
throughout the study were interviewed as well as 12 (out of 14)
regular support-staff.
3.1.7. Organisational constraints
Every one of the ﬁve pharmacists was observed adopting
several roles, as evidenced by other research [34], including
dispenser, patient advocate, manager and health service provider.
Pharmacists’ heavy engagement in the dispensing process meant
that most MURs were performed opportunistically when the
pharmacy was less busy. With no additional stafﬁng, MURs had
been poorly integrated into the pharmacists’ daily activities. In
their interviews, pharmacists indicated that they felt constrained
to speed through the MUR by the need to return to their ‘routine’
duties in the pharmacy (Box 6). Pharmacists, particularly those
working for the multiple, reported feeling pressurised to deliver a
targeted number of MURs. One pharmacist revealed that she
purposefully chose patients on fewer medicines or simpler regimes
that could be performed quickly despite acknowledging that those
on more medicines or complex regimes potentially stood to beneﬁt
more:
Jane: . . . you see a massive script, you think I don’t want to do an
MUR on that. But though, probably they would be the best people
who would get the most out of it. You see a prescription that’s got
maybe two items on it, dead easy. . .the emphasis is on targets so
Theme: Staffing:
Cath: . . .it’s not practical for us to get two pharmacists . . .it’s
expense you’re paying for two pharmacists at once. . . again it’s
money isn’t it? How practical would it be to get another
pharmacist. . .
Counter assistant, Independent
Stef: . . .they won’t give us two pharmacists every day will
they. . .so long as one is available.
Counter assistant, Multiple
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trying to get, do the easiest ones possible to get the numbers rather
than concentrating on getting those that perhaps would beneﬁt
from it.
Employee pharmacist, Multiple
Support-staff reported tensions with patients who were
awaiting prescriptions and with those wishing to speak with a
pharmacist while the pharmacist was performing an MUR (Box 6).
Support-staff were aware that they could interrupt the pharma-
cist in these circumstances and made personal judgements
between interrupting a private consultation and appeasing
waiting patients.
4. Discussion and conclusion
4.1. Discussion
Pharmacists in this study adhered to a format for conducting
MURs which was largely determined by the structure of the MUR
form. Although pharmacists fulﬁlled their obligation of asking the
questions, the consultation left patients little scope for a more open
discussion of their medicines. Pharmacists delivered information
in an instructional manner in a way that was similar to their
interaction with patients while dispensing medicines. These
ﬁndings support previous literature indicating that the pharma-
cist’s conversational turn aims to promote their agenda rather than
altering in response to what the patient said; the pharmacist
remained focused on the medicine rather than the patient’s illness
[35,36]. MURs have been criticised for promoting a professional
agenda focusing on patient compliance, rather than concordance
[37]. Consultation skills such as responding to patient cues, using
open questions and eliciting the patient’s perspective have been
identiﬁed by others as areas that pharmacists need to improve
[38]. Constrained by their remit, pharmacists were reluctant to
engage with contentious or problematic issues and this meant that
opportunities were lost for meaningful engagement. Far from
providing an opportunity to develop skills and extend their
professional authority, the routinised nature of the MUR reduced
the pharmacists’ scope for exercising professional judgement and
autonomy. Nevertheless, most patients valued the time the
pharmacist spent with them and the privacy of the MUR
consultation. They saw pharmacists as knowledgeable experts
who were able to reassure them about their medicines, supporting
evidence that suggests beneﬁt in developing community pharma-
cists’ role both as a reviewer of patients’ medicines and as an
adviser [39].
In contrast to their handling of the MURs, this study showed
that pharmacists could provide customised information in
responding to patient requests for advice about minor ailments.
In these circumstances, patients appeared both familiar with and
accepted the role of the pharmacist as an accessible adviser. The
autonomy and willingness of the pharmacists to accommodatepatient preferences during OTC discussions was in contrast to
their constrained approach when discussing prescribed medi-
cines during the MUR. Whereas the pharmacists’ role in
dispensing and OTC activity could be conceptualised as a
transformative activity, where the inert drug is transformed
into a medicine for the individual patient [40,41], MUR activity
was not observed to contribute to this process. Adopting a
formulaic approach when ﬁlling out the questions on the MUR
form left little room for discussions beyond the simple ‘checking’
of medicines.
The perceived pressure to pursue a targeted number of MURs
was more prominent within the multiple and pharmacists
reported dissatisfaction over the issue. Other studies have reported
similar ﬁndings [42,43] suggesting that pharmacies are being
remunerated for MURs which are not targeted at patients who may
beneﬁt most, leading to concerns over their value [44]. In this way,
the commercialisation of MUR activity challenged rather than
enhanced pharmacists’ professional status; a ﬁnding highlighted
by others [42,45]. Harding and Taylor warned simply: ‘asking
structured, formulaic questions’ [41]. The MURs observed were at
odds with policy commitments and strategies to develop a
responsive service which is individually tailored and patient-
centred [1,9].
To our knowledge this is the only observational study that has
explored patient–pharmacist interactions and MUR consultations
as they occurred naturally in practice. These ﬁndings make a
signiﬁcant contribution to the analysis of current pharmacy
practice adding to existing doubts about the extent to which the
MUR service is meeting its stated aims [42]. Limitations of this
study include the unknown effect of the researcher’s presence on
the pharmacy staff’s behaviour and on the pharmacist and patient
during the MUR consultation. The longitudinal nature of the study
was intended to reduce the extent to which participants modify
behaviour as a result of a heightened awareness of the observer.
Furthermore, audio or video recording the MUR consultation
would have provided verbatim data. Nevertheless, it was decided
that hand written notes would be used by the researcher to record
the MUR consultation because of ethical considerations [32]. Only
two pharmacies were investigated and the observations made by
one researcher. Further research of patients’ experience of MURs is
clearly needed and in a wider and more diverse range of
community pharmacy settings. Additional research should also
investigate whether better targeting of MURs improves their
outcome or whether this depends upon widening the pharmacist’s
remit when performing an MUR and improving their consultation
skills.
4.2. Conclusion
MURs provide a nationally recognised counseling role for UK
community pharmacists. However, several factors hindered
pharmacists’ capacity to engage effectively with patients. Phar-
macists’ heavy commitment to the dispensing process meant there
was poor integration of the MUR service into their routine
workload. Patients were unaccustomed to having a consultation
with the pharmacist and lacked awareness of what it could offer.
Consultations therefore served professional objectives rather than
being patient-centred. The interactions and advice given within
MUR consultations were predominantly instructional and resem-
bled interactions about dispensed medicines. During OTC con-
sultations, pharmacists involved patients to a greater extent
indicating they already have many skills to effectively engage
patients in decisions about their healthcare. However, pharmacists
failed to take full advantage of the opportunities offered by MURs
to fully involve patients, being constrained by situational pressures
and commercial intent.
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Although well intentioned, the MUR service is not realising its
aim to improve patients’ knowledge, understanding and use of
medicines. Substantial changes to current practice are needed. If
pharmacists are to engage in new consultative services a review of
their communication skills training is required so they can better
elicit and engage with patients’ perspectives and concerns about
taking medicines. Changes to policy also need to be considered
particularly the way organisations implement and incentivise
pharmacists to perform MURs so that patients who may beneﬁt
most are better targeted and pharmacists have the requisite space
and time to incorporate MURs within their routine practice.
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